ALISON GIBSON: Open Payments
NPI 1619950037 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 21 payments from 10 companies in 2025. Trend: 2023 $681 · 2024 $741 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $101 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Novo Nordisk Inc | 3 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Stryker Corporation | 1 | $27 |
| Boston Scientific Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: VERQUVO, Wegovy, OPSYNVI, JARDIANCE, CAMZYOS, LifeVest, INSPIRE, ARTIX MT.
Industry payments across TX — which companies pay providers there.
